Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Xenon Pharmaceuticals Inc. | Director | Common Shares | 7.14K | $218K | $30.48 | Jun 5, 2025 | Direct |
Fusion Pharmaceuticals Inc. | Director | Common Stock | 0 | $134K | $2.38 | Jun 4, 2024 | Direct |
Xenon Pharmaceuticals Inc. | Director | Share Option (Right to Buy) | 17K | Jun 5, 2025 | Direct | ||
Xenon Pharmaceuticals Inc. | Director | Restricted Share Units | 2.65K | Jun 5, 2025 | Direct | ||
Fusion Pharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 0 | Jun 4, 2024 | Direct | ||
Xenon Pharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 0 | May 14, 2025 | Direct |